BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27532114)

  • 1. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ; Nagi AH; Naseem N
    Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
    Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
    Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
    Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
    Murase Y; Iwata H; Takahara T; Tsuzuki T
    Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
    Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of MCM-2 in invasive breast carcinoma: a stereologic approach.
    Cobanoglu U; Mungan S; Gundogdu C; Ersoz S; Ozoran Y; Aydin F
    Bratisl Lek Listy; 2010; 111(1):45-9. PubMed ID: 20429312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma.
    Oda T; Takahashi A; Miyao N; Yanase M; Masumori N; Itoh N; Sato MA; Kon S; Tsukamoto T
    Int J Urol; 2003 Jan; 10(1):13-8. PubMed ID: 12534920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein expression according to the grade of atypism in actinic keratosis.
    Shin JW; Kim YK; Cho KH
    Am J Dermatopathol; 2010 Dec; 32(8):794-8. PubMed ID: 20847638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.